Key facts
- Pattern BioSciences’s last known valuation is $6.2M (May 2019).
- It has raised $82.2M; the latest was Later Stage VC ($43.0M) in Nov 2025.
- Notable investors include Valor Equity Partners, Illumina Ventures, AMR Action Fund, BaseLaunch, EASME - EU Executive Agency for SMEs — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Pattern BioSciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Pattern BioSciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pattern BioSciences
Developer of a biotechnology platform intended to treat cancer and other diseases. The company's platform develops gene therapies by using gene circuit technologies by targeting combinations of molecules, instead of single molecules, enabling medical professionals to improve patient outcomes and create a value for the healthcare system.
- Sector
- Healthcare
- HQ
- South San Francisco, CA, United States
- Founded
- 2018
- Employees
- 8
- Website
- patternbio.com/
- Ownership
- Privately Held (backing)
Pattern BioSciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pattern BioSciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pattern BioSciences in its N-PORT filings yet. We sweep new filings monthly.